ATLAS initiative is to recruit 150,000 patients across the health system to build the world’s largest genomic resource that can be used for translational medicine. A large-scale collection of diverse patient blood, saliva, and tissue samples are genotyped for researchers and clinicians to analyze the data with clinical, environmental, and life style information and deliver the best care to our patients. Patients’ participation is voluntary and their privacy is protected by de-identifying the samples.
UCLA Health is committed to help patients make an informed decision about participating in ATLAS. At our participating locations, patients are offered an iPad to watch the Universal Consent video that explains the study goals and how it works. Then they are presented with an option to either opt-in or decline participation. As the bio-samples become available for patients who have selected to participate in ATLAS study, UCLA Biobank picks up samples and de-identifies them for DNA extraction and genotyping.